Fed Circ denies Sun Pharma patent for alopecia treatment

24-08-2023

Liz Hockley

Fed Circ denies Sun Pharma patent for alopecia treatment

Pavel Kapysh / Shutterstock.com

Indian drugmaker had challenged PTAB decision that patent for new version of ruxolitinib was invalid as obvious | Decision hands a victory to US rival.


Sun Pharmaceutical, alopecia, Incyte, patent, ruxolitinib

LSIPR